133 related articles for article (PubMed ID: 7765673)
1. Clarification of the Australian Patent Office's implementation of the Budapest Treaty.
Kurts A
Australas Biotechnol; 1994; 4(5):278-9. PubMed ID: 7765673
[No Abstract] [Full Text] [Related]
2. "Sufficiency" for living organism inventions under the Patents Act 1990 (Cth).
Lawson C
J Law Med; 2004 Feb; 11(3):373-81. PubMed ID: 15018213
[TBL] [Abstract][Full Text] [Related]
3. Patentable subject matter, TRIPS and the European Biotechnology Directive: Australia and patenting human genes.
Palombi L
Univ N S W Law J; 2003; 26(3):782-92. PubMed ID: 16617532
[No Abstract] [Full Text] [Related]
4. The patenting of novel biotech products.
Webber PM
IDrugs; 2007 Jul; 10(7):459-62. PubMed ID: 17642015
[TBL] [Abstract][Full Text] [Related]
5. International patent law-boon or bane of biotech?
Basu P
Nat Biotechnol; 2005 Jan; 23(1):13-5. PubMed ID: 15637604
[No Abstract] [Full Text] [Related]
6. Patent pools and standard setting in diagnostic genetics.
Ebersole TJ; Guthrie MC; Goldstein JA
Nat Biotechnol; 2005 Aug; 23(8):937-8. PubMed ID: 16082359
[No Abstract] [Full Text] [Related]
7. Patenting in biotechnology: a review of the 20th symposium of ECB8.
Szarka E
J Biotechnol; 1999 Jan; 67(1):1-11. PubMed ID: 9987844
[TBL] [Abstract][Full Text] [Related]
8. Towards harmonization: the European biotechnology patent directive.
Curley D
J Biolaw Bus; 2002; 5(3):64-8. PubMed ID: 12816122
[TBL] [Abstract][Full Text] [Related]
9. Quality patents.
Sinclair K
Australas Biotechnol; 1994; 4(5):284. PubMed ID: 7765675
[TBL] [Abstract][Full Text] [Related]
10. Australia experiments with 'experimental use' exemption.
McBratney A; Nielsen K; McMillan F
Nat Biotechnol; 2004 Aug; 22(8):1023-5. PubMed ID: 15286651
[TBL] [Abstract][Full Text] [Related]
11. Preservation of microorganisms as deposits for patent application.
Cameotra SS
Biochem Biophys Res Commun; 2007 Feb; 353(4):849-50. PubMed ID: 17189611
[No Abstract] [Full Text] [Related]
12. European patent office's stem-cell decision.
Nat Rev Drug Discov; 2009 Jan; 8(1):12. PubMed ID: 19116622
[No Abstract] [Full Text] [Related]
13. Biotech in post-TRIPS India.
Ramani SV; Pradhan P; Ravi M
Nat Biotechnol; 2005 Jan; 23(1):18-9. PubMed ID: 15637608
[No Abstract] [Full Text] [Related]
14. Patents on parts of the human body: salient issues under EC and WTO law.
Herdegen M
J World Intellect Prop; 2002 Mar; 5(2):145-55. PubMed ID: 15986546
[No Abstract] [Full Text] [Related]
15. How can the developing world protect itself from biotech patent-holders?
Barton JH; Strauss J
Nature; 2000 Aug; 406(6795):455. PubMed ID: 10952285
[No Abstract] [Full Text] [Related]
16. International patent filing. Factors to consider in deciding when and where to file outside the United States.
Agris CH
Nat Biotechnol; 1998 May; 16(5):479-80. PubMed ID: 9592399
[No Abstract] [Full Text] [Related]
17. Patentability of biotechnological inventions in countries of the Pacific Rim.
Cox GB; Wong SS; Waters S; Santer VB
Australas Biotechnol; 1994; 4(5):274-7. PubMed ID: 7765672
[No Abstract] [Full Text] [Related]
18. The morality of biotech patents: differing legal obligations in Europe?
Ford R
Eur Intellect Prop Rev; 1997 Jun; 19(6):315-8. PubMed ID: 16538738
[No Abstract] [Full Text] [Related]
19. Intellectual property protection for plant-related inventions in Europe.
Fleck B; Baldock C
Nat Rev Genet; 2003 Oct; 4(10):834-8. PubMed ID: 14526379
[TBL] [Abstract][Full Text] [Related]
20. Analyzing the impact of the European unitary patent system on worldwide biotechnology.
Belda I; Penas G; Marquina D; Santos A
Trends Biotechnol; 2014 Aug; 32(8):393-5. PubMed ID: 25059513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
